Bibliography | Clinical Research Centre
CANCER:COLORECTAL
CASE REPORT:
1. Fadli A, Azmi M, David O, et al. Isolated metacarpal bone metastasis from advanced
rectosigmoid carcinoma. International Medical Journal (IIUM) 2012;11(1):52-62
http://iiumedic.net/imjm/v1/download/Volume%2011%20No%201/IMJM%20Vol11No1-2012p59-62.pdf.
HEALTH SYSTEMS:
2. Magaji BA, Moy FM, April Camilla R, et al. Health-related quality of life among colorectal
cancer patients in Malaysia: a study protocol. BMC Cancer 2012;12:384-2407-12-384
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443003/.
PUBLIC HEALTH:
3. Rajendra S, Ho JJ. Colonic diverticular disease in a multiracial Asian patient population
has an ethnic predilection. Eur J Gastroenterol Hepatol 2005;17(8):871-875.
CLINICAL:
4. Azmi MN, Zailani MA, Norashikin MN, et al. Five-year review of histopathological findings
of colorectal cancer patients operated in Hospital Tengku Ampuan Afzan, Kuantan, Pahang,
Malaysia. International Medical Journal (IIUM) 2007;6(1)
http://www.e-imj.com/Vol6-No1/Vol6-No1-B3.htm.
HEALTH MANAGEMENT:
5. Mohamed AQ. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer
in Malaysia. Malaysian Society of Gastroenterology & Hepatology, College of Surgeons of
Malaysia, Academy of Medicine of Malaysia 2001;.
6. Qureshi MA. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer
in Malaysia. 2001;.
LAB BASED STUDY – GENETIC EPIDEMIOLOGY:
7. Chew MF, Teoh KH, Cheah PL. CD133 marks for colorectal adenocarcinoma. Malays J
Pathol 2012;34(1):25-28
http://www.mjpath.org.my/2012.1/CD133.pdf.
HEALTH SYSTEMS:
8. Sharifa Ezat WP, Natrah MS, Syed Mohd A, et al. Quality of life in Malaysian colorectal
cancer patients. Asia Pac Psychiatry 2013;5 Suppl 1:110-117
http://onlinelibrary.wiley.com/doi/10.1111/appy.12055/pdf.
PUBLIC HEALTH:
9. Loh KW, Hazreen AM, Maznah D, et al. Sociodemographic predictors of recall and
recognition of colorectal cancer symptoms and anticipated delay in help- seeking in a
multiethnic asian population. Asian Pac J Cancer Prev 2013;14(6):3799-3804
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3799804%205.19%20Kwong%20Weng%20Loh.pdf.
10. Yunus AG. Surgical management of rectal cancer - no room for error. Malaysian Journal
of Medicine and Health Sciences 2008;4(1):iii-iv
http://medic.upm.edu.my/images/stories/journal/VOL4NO1_JANUARY2008.pdf;;.
HEALTH BEHAVIOUR
11. Al-Naggar RA, Bobryshev YV. Knowledge of colorectal cancer screening among young
Malaysians. Asian Pac J Cancer Prev 2013;14(3):1969-1974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/%20196974%202.21%20Redhwan%20A%20Al-Naggar.pdf.
LAB BASED – GENETIC EPID
12. Zahary MN, Ahmad Aizat AA, Gurjeet Kaur, et al. Contribution of the MLH1 -93G>a
promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer
patients. Asian Pac J Cancer Prev 2013;14(2):619-624
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/619624%208.13%20Zahary%20Mohd%20Nizam.pdf.
HEALTH BEHAVIOUR
13. Harmy MY, Norwati D, Norhayati MN, et al. Participation and barriers to colorectal
cancer screening in Malaysia. Asian Pac J Cancer Prev 2012;13(8):3983-3987
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/398387%207.24%20Harmy%20Mohamed%20Yusof.pdf.
CLINICAL
14. Ulaganathan V, Kandiah M, Zalilah MS, et al. Colorectal cancer and its association with
the metabolic syndrome: a Malaysian multi-centric case-control study. Asian Pac J Cancer
Prev 2012;13(8):3873-3877
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/387377%207.16%20Vaidehi%20Ulaganathan.pdf.
LAB BASED
15. Ashwaq Hamid Y, Narazah MY, Imran AK, et al. Pilot study of the sensitivity and
specificity of the DNA integrity assay for stool-based detection of colorectal cancer in
Malaysian patients. Asian Pac J Cancer Prev 2012;13(5):1869-1872
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/186972%204.1%20Ashwaq%20Hamid%20Yehya.pdf.
PUBLIC HEALTH:
16. Al-Jashamy K, Murad A, Zeehaida M, et al. Prevalence of colorectal cancer associated
with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract
disease patients. Asian Pac J Cancer Prev 2010;11(6):1765-1768
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20176568%2010.20%20Al-Jashamy%20Karim.pdf.
17. Kong C, April Camilla R, Law C, et al. Impact of socio-economic class on colorectal
cancer patient outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pac J Cancer Prev
2010;11(4):969-974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%2096974%20Kong.pdf.
18. Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with metabolic
diseases; experience with 138 cases from Kelantan, Malaysia. Asian Pac J Cancer Prev
2008;9(4):747-751
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c%20Othman.pdf.
19. Mohd Radzniwan AR, Aznida Firzah AA, Saharuddin A, et al. Colorectal cancer patients
in a tertiary referral centre in Malaysia: a five year follow-up review. Asian Pac J Cancer
Prev 2009;10(6):1163-1166
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1163_c_Rashid.pdf.
20. Mirnalini K, Amutha R, Zalilah MS, et al. Diet and lifestyle intervention among patients
with colorectal adenomas: rationale and design of a Malaysian study. Asian Pac J Cancer
Prev 2005;6(4):553-560
http://www.apocpcontrol.org/paper_file/issue_abs/Volume6_No4/Mirnalini%20Kandiah.pdf.
HEALTH BEHAVIOUR
21. Husna AA, Loh SY, Low WY, et al. Quality of life of multiethnic adolescents living with a
parent with cancer. Asian Pac J Cancer Prev 2012;13(12):6289-6294
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No12/628994%2011.10%20Husna%20A%20Ainuddin.pdf.
HEALTH BEHAVIOUR
22. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Perceptions of Malaysian
colorectal cancer patients regarding dietary intake: a qualitative exploration. Asian Pac J
Cancer Prev 2013;14(2):1151-1154
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/115154%201.4%20Afzaninawati%20Suria%20Yusof.pdf.
PUBLIC HEALTH
23. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Dietary patterns and risk of
colorectal cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer
Prev 2012;13(9):4713-4717
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/47137%208.16%20Afzaninawati%20Suria%20Yusof.pdf.
CLINICAL
24. Syahnaz MH, Khairani O, Tong SF, et al. Factors influencing late consultation among
patients with rectal bleeding in University Kebangsaan Malaysia Medical Centre. Asian Pac
J Cancer Prev 2010;11(5):1335-1339
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%20133539%209.27%20Ismail%20Sagap.pdf.
HEALTH BEHAVIOUR
25. Syahnaz MH, Tong SF, Khairani O, et al. Knowledge of colorectal cancer among patients
presenting with rectal bleeding and its association with delay in seeking medical advice.
Asian Pac J Cancer Prev 2011;12(8):2007-2011
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/200711%20c7.28%20Hashim.pdf.
CLINICAL
26. Ahmed SA, Rand RH, Layla KM, et al. Investigation into the controversial association of
Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009;9:4032407-9-403
http://www.biomedcentral.com.ezp.imu.edu.my/content/pdf/1471-2407-9-403.pdf.
LAB STUDIES
27. Abdul Aziz AA, Siti Nurfatimah MS, Mohd Aminudin M, et al. Association of Arg72Pro of
P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian
Pac J Cancer Prev 2011;12(11):2909-2913
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No11/290913%20c10.19%20Aizat.pdf.
CLINICAL
28. Ahmed SA, Rand RH, Fatimah AB. The association of Streptococcus bovis/gallolyticus
with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J
Exp Clin Cancer Res 2011;30:11-9966-30-11
http://www.jeccr.com/content/pdf/1756-9966-30-11.pdf.
LAB STUDIES
29. Ahmed SA, Rand RH, Fatimah AB. Molecular detection, quantification, and isolation of
Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven
potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 2010;9:249-4598-9-249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946291/pdf/1476-4598-9-249.pdf.
30. Mohamed KA, Abdalrahim FAA, Zeyad DN, et al. Cat's whiskers tea (Orthosiphon
stamineus) extract inhibits growth of colon tumor in nude mice and angiogenesis in
endothelial cells via suppressing VEGFR phosphorylation. Nutr Cancer 2012;64(1):89-99
http://ezproxy.upm.edu.my:2085/doi/pdf/10.1080/01635581.2012.630160.
31. Balraj P, Ruhana S. PTEN mutation studies in Malaysian colorectal cancer patients. Asia
Pacific Journal of Molecular Biology and Biotechnology 2007;15(1):23-25
http://www.msmbb.org.my/apjmbb/html151/151d.pdf.
32. Fatemeh A, Maznah I, Hosseinkhani H, et al. Effects of CXCR4 siRNA/dextran-spermine
nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal
cancer metastasis to the liver. Cancer Manag Res 2011;3:301-309
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173020/pdf/cmr-3-301.pdf.
33. Chandramathi S, Suresh KG, Anita ZB, et al. Attenuation of hydrogen peroxide and
ferric reducing/antioxidant power serum levels in colorectal cancer patients with intestinal
parasitic infection. Malays J Med Sci 2009;16(2):15-20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336169/pdf/mjms-16-2-015.pdf.
34. Lim SR, Gooi BH, Singh M, et al. Analysis of differentially expressed proteins in
colorectal cancer using hydroxyapatite column and SDS-PAGE. Appl Biochem Biotechnol
2011;165(5-6):1211-1224.
PUBLIC HEALTH
35. Hilmi I, Goh KL. Commentary: adherence and detection rates in colorectal cancer
screening. Aliment Pharmacol Ther 2013;37(1):156-7; discussion 157-8.
HEALTH BEHAVIOUR
36. Koo JH, Leong RW, Ching J, et al. Knowledge of, attitudes toward, and barriers to
participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter
study. Gastrointest Endosc 2012;76(1):126-135.
CLNICAL
37. Wendy L, Radzi M. New registry: National Cancer Patient Registry--Colorectal Cancer.
Med J Malaysia 2008;63 Suppl C:57-58.
LAB STUDIES
38. Mirakhorli M, Rahman SA, Abdullah S, et al. Multidrug resistance protein 2 genetic
polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4
chemotherapy. Mol Med Rep 2013;7(2):613-617.
39. Ho K, Yazan LS, Ismail N, et al. Apoptosis and cell cycle arrest of human colorectal
cancer cell line HT-29 induced by vanillin. Cancer Epidemiol 2009;33(2):155-160.
CLINICAL
40. Tan YM, Rosmawati M, Ranjeev P, et al. Predictive factors by multivariate analysis for
colorectal cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol
2002;17(3):281-284.
41. Roslani AC, Abdullah T, Arumugam K. Screening for colorectal neoplasias with fecal
occult blood tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev
2012;13(1):237-241.
42. Ghazali AK, Musa KI, Naing NN, et al. Prognostic factors in patients with colorectal
cancer at Hospital Universiti Sains Malaysia. Asian J Surg 2010;33(3):127-133.
43. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis
2007;8(4):179-185.
LAB STUDIES
44. Tan LP, Ng BK, Balraj P, et al. No difference in the occurrence of mismatch repair
defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient
cohort. Pathology 2007;39(2):228-234.
45. Yip WK, Choo CW, Leong VC, et al. Molecular alterations of Ras-Raf-mitogen-activated
protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal
cancers from a tertiary hospital at Kuala Lumpur, Malaysia. APMIS 2013;121(10):954-966.
46. Abdul Murad NA, Othman Z, Khalid M, et al. Missense mutations in MLH1, MSH2, KRAS,
and APC genes in colorectal cancer patients in Malaysia. Dig Dis Sci 2012;57(11):28632872.
47. Davoodi H, Seow HF. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and
Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy
Asthma Immunol 2011;10(2):91-99.
48. Zulhabri O, Rahman J, Ismail S, et al. Predominance of G to A codon 12 mutation K-ras
gene in Dukes' B colorectal cancer. Singapore Med J 2012;53(1):26-31
http://www.ncbi.nlm.nih.gov/pubmed/22252179.
49. Yam YY, Hoh BP, Othman NH, et al. Somatic copy-neutral loss of heterozygosity and
copy number abnormalities in Malaysian sporadic colorectal carcinoma patients. Genet Mol
Res 2013;12(1):319-327.
50. Ching-Shian Leong V, Jabal MF, Leong PP, et al. PIK3CA gene mutations in breast
carcinoma in Malaysian patients. Cancer Genet Cytogenet 2008;187(2):74-79.
HEALTH BEHAVIOUR
51. Harmy MY, Norwati D, Noor NM, et al. Knowledge and attitude of colorectal cancer
screening among moderate risk patients in West Malaysia. Asian Pac J Cancer Prev
2011;12(8):1957-1960.
52. Hilmi I, Hartono JL, Goh K. Negative perception in those at highest risk--potential
challenges in colorectal cancer screening in an urban asian population. Asian Pac J Cancer
Prev 2010;11(3):815-822.
CLINICAL
53. Gul YA. Management of colorectal cancer--can we do better? Med J Malaysia
2008;63(2):89-90
http://www.e-mjm.org/2008/v63n2/Colorectal_Cancer.pdf.
LAB STUDIES
54. Chandramathi S, Suresh K, Anita ZB, et al. Infections of Blastocystis hominis and
microsporidia in cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg
2012;106(4):267-269.
CLINICAL
55. Kamil M, Haron M, Yosuff N, et al. High frequency of hand foot syndrome with
capecitabine. J Coll Physicians Surg Pak 2010;20(6):421-422.
CASE REPORT
56. Ng CV. Hypersensitivity reactions to oxaliplatin in two asian patients. Ann
Pharmacother 2005;39(6):1114-1118.
CLINICAL
57. Dranitsaris G, Truter I, Lubbe MS. The development of a value based pricing index for
new drugs in metastatic colorectal cancer. Eur J Cancer 2011;47(9):1299-1304.
LAB STUDIES
58. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 mediate 2-(3,4dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and
colorectal cancer cells. Mol Cancer Ther 2011;10(10):1982-1992.
CLINICAL
59. Amutha R, Mirnalini K. Food intake and colorectal adenomas: a case-control study in
Malaysia. Asian Pac J Cancer Prev 2009;10(5):925-932
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/925%20Ramadas.pdf.
LAB STUDIES
60. Khor TO, Gul YA, Ithnin H, et al. Positive correlation between overexpression of
phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal
carcinoma. Cancer Lett 2004;210(2):139-150.
61. Khor TO, Gul YA, Ithnin H, et al. A comparative study of the expression of Wnt-1, WISP1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 2006;21(4):291-300.
62. Chan KH, Chandramathi S, Suresh K, et al. Effects of symptomatic and asymptomatic
isolates of Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res
2012;110(6):2475-2480.
63. Chandramathi S, Suresh K, Kuppusamy UR. Solubilized antigen of Blastocystis hominis
facilitates the growth of human colorectal cancer cells, HCT116. Parasitol Res
2010;106(4):941-945.
64. Jada SR, Lim R, Wong CI, et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A
polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci
2007;98(9):1461-1467.
65. Yaacob NS, Darus HM, Norazmi MN. Modulation of cell growth and PPARgamma
expression in human colorectal cancer cell lines by ciglitazone. Exp Toxicol Pathol
2008;60(6):505-512.
CLINICAL
66. Hilmi I, Goh KL. Chemoprevention of colorectal cancer with nonsteroidal antiinflammatory drugs. Chin J Dig Dis 2006;7(1):1-6.
LAB STUDIES
67. Hong SK, Gul YA, Ithnin H, et al. Expression of beta-catenin, COX-2 and iNOS in
colorectal cancer: relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia. Asian J
Surg 2004;27(1):10-17.
CLINICAL
68. Teoh CM, Gunasegaram T, Chan KY, et al. Review of risk factors associated with the
anastomosis leakage in anterior resection in Hospital Universiti Kebangsaan Malaysia. Med
J Malaysia 2005;60(3):275-280
http://www.e-mjm.org/2005/v60n3/Anastomosis_Leakage.pdf.
LAB STUDIES
69. Naik VR, Jaafar H, Seng CE. Lymphatic channel density in colorectal adenocarcinoma.
Indian J Pathol Microbiol 2010;53(1):12-14.
CLINICAL
70. bin Sabir Husin Athar PP, bte Ahmad Norhan N, bin Saim L, et al. Metastasis to the
sinonasal tract from sigmoid colon adenocarcinoma. Ann Acad Med Singapore
2008;37(9):788-783.
LAB STUDIES
71. Rajendra S, Ho JJ, Arokiasamy J. Risk of colorectal adenomas in a multiethnic Asian
patient population: race does not matter. J Gastroenterol Hepatol 2005;20(1):51-55.
72. Goh KS, Ong TA, Peh SC, et al. P53 expression in colorectal carcinoma: the University
of Malaya Medical Centre's experience. Med J Malaysia 2004;59(4):515-521
http://www.e-mjm.org/2004/v59n4/Colorectal_Carcinoma.pdf.
HEALTH BEHAVIOUR
73. Natrah MS, Ezat S, Syed MA, et al. Quality of life in Malaysian colorectal cancer
patients: a preliminary result. Asian Pac J Cancer Prev 2012;13(3):957-962.
CLINICAL
74. Mahadeva S, Rembacken BJ. Standard "inject and cut" endoscopic mucosal resection
technique is practical and effective in the management of superficial colorectal
neoplasms. Surg Endosc 2009;23(2):417-422.
LAB STUDIES
75. Chandramathi S, Suresh K, Anita ZB, et al. Comparative assessment of urinary
oxidative indices in breast and colorectal cancer patients. J Cancer Res Clin Oncol
2009;135(2):319-323.
CLINICAL
76. Primrose JN. Managing liver metastases: myth or reality? Med J Malaysia 2005;60 Suppl
B:67-69.
77. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping
in colorectal cancer. ANZ J Surg 2008;78(9):775-779.
LAB STUDIES
78. Chan TH, Goh KL. Appropriateness of colonoscopy using the ASGE guidelines:
experience in a large Asian hospital. Chin J Dig Dis 2006;7(1):24-32.
79. Lim MS, Melich G, Min BS. Robotic single-incision anterior resection for sigmoid colon
cancer: access port creation and operative technique. Surg Endosc 2013;27(3):1021-0122549-0. Epub 2012 Oct 10.
CLINICAL
80. Cheong KL, Roohi S, Jarmin R, et al. The yield for colorectal cancer and adenoma by
indication at colonoscopy. Med J Malaysia 2000;55(4):464-466
http://www.e-mjm.org/2000/v55n4/Colonoscopy.pdf.
LAB STUDIES
81. Lim SR, Gooi BH, Gam LH. Identification of low abundance proteins in colorectal cancer
tissues. Cancer Biomark 2012;12(4):185-198.
HEALTH BEHAVIOUR
82. Goh KL, Quek KF, Yeo GT, et al. Colorectal cancer in Asians: a demographic and
anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther
2005;22(9):859-864.
LAB STUDIES
83. Aisha AF, Abu-Salah KM, Ismail Z, et al. alpha-Mangostin enhances betulinic acid
cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells.
Molecules 2012;17(3):2939-2954.
84. Nassar ZD, Aisha AF, Idris N, et al. Koetjapic acid, a natural triterpenoid, induces
apoptosis in colon cancer cells. Oncol Rep 2012;27(3):727-733.
85. Ashok Kumar P, Norhaizan ME. Dietary non-nutritive factors in targeting of regulatory
molecules in colorectal cancer: an update. Asian Pac J Cancer Prev 2013;14(10):5543-5552
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/55435552%207.25%20Ashok%20Kumar%20Pandurangan%20%28REVIEW%29.pdf.
86. Leong BD, Ramu P, Kumar VM, et al. Synchronous adenocarcinoma of caecum,
transverse colon and jejunum. Med J Malaysia 2008;63(2):148-149
http://www.e-mjm.org/2008/v63n2/Synchronous_Adenocarcinoma.pdf.
87. Rajendra S, Kutty K, Karim N. Flat colonic adenomas in Malaysia: fact or fancy? J
Gastroenterol Hepatol 2003;18(6):701-704.
88. Tan LP, Ng BK, Balraj P, et al. Gene symbol: APC. Disease: colorectal cancer. Hum
Genet 2005;118(3-4):545.
89. Venkatesh RN, Jaafar H, Mutum SS. Heterotopic ossification in skeletal muscle
metastasis from colonic adenocarcinoma--a case report. Malays J Pathol 2005;27(2):119121
http://www.mjpath.org.my/past_issue/MJP2005.2/08Heteropic.pdf.
CLINICAL
90. Harris Ngow A, Wan Khairina W. Cardiac mass in a patient with sigmoid
adenocarcinoma: a metastasis? Cardiovasc J Afr 2012;23(7):e10-e12
http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=22915057&site=ehostlive.
CASE REPORT
91. Chan KY, Teoh CM, Sukumar N. Chylous ascites after anterior resection for rectal
carcinoma: a rare but significant incident. Asian J Surg 2006;29(1):46-48.
LAB STUDIES
92. Hisham RB, Thuaibah H, Gul YA. Mucinous adenocarcinoma of the rectum with breast
and ocular metastases. Asian J Surg 2006;29(2):95-97.
CASE REPORT
93. Jasman J, Mayuha R, Imtiaz H, et al. Subcutaneous metastases from rectal carcinoma:
A case report. Journal of Surgical Academia 2011;1(2):23
http://journalarticle.ukm.my/2960/1/23-24.pdf.
CLINICAL
94. Law CW, Roslani AC, Ng LL. Treatment delay in rectal cancer. Med J Malaysia
2009;64(2):163-165.
95. Lee WC, Mastura MY, Lau FN, et al. Preoperative long course chemoirradiation in a
developing country for rectal carcinoma: Kuala Lumpur Hospital experience. Asian Pac J
Cancer Prev 2013;14(6):3941-3944
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3941-44%205.27%20Wei
%20Ching%20Lee.pdf.
CASE REPORT
96. Ramanathan Y, Rajagopalan R, Rahman NA. Laryngeal metastasis from a rectal
carcinoma. Ear Nose Throat J 2007;86(11):685-686.
LAB STUDIES
97. Siti Aisyah AG, Maznah I, Latifah SY, et al. Cytotoxic Activity of Kenaf Seed Oils from
Supercritical Carbon Dioxide Fluid Extraction towards Human Colorectal Cancer (HT29) Cell
Lines. Evid Based Complement Alternat Med 2013;2013:549705
http://www.hindawi.com/journals/ecam/2013/549705/.
98. Al-Joudi FS. Prognostic value of an index for serum globulin compensation in colon and
breast cancers. Singapore Med J 2005;46(12):710-713
http://www.sma.org.sg/smj/4612/4612a5.pdf.
99. Nazri A, Lio P. Investigating meta-approaches for reconstructing gene networks in a
mammalian cellular context. PLoS One 2012;7(1):e28713
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253778/.
100. Ahmad Aizat AA, Siti Nurfatimah MS, Aminudin MM, et al. XPC Lys939Gln
polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians. World J
Gastroenterol 2013;19(23):3623-3628
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691041/.
CLINICAL
101. Chan KK, Dassanayake B, Deen R, et al. Young patients with colorectal cancer have
poor survival in the first twenty months after operation and predictable survival in the
medium and long-term: analysis of survival and prognostic markers. World J Surg Oncol
2010;8:82-7819-8-82
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954852/.
LAB STUDIES
102. Ho KL, Chong PP, Yazan LS, et al. Vanillin differentially affects azoxymethane-injected
rat colon carcinogenesis and gene expression. J Med Food 2012;15(12):1096-1102
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523249/.
103. Kaur G, Masoud A, Raihan N, et al. Mismatch repair genes expression defects &
association with clinicopathological characteristics in colorectal carcinoma. Indian J Med
Res 2011;134:186-192
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181019/.
104. Liong MT. Roles of probiotics and prebiotics in colon cancer prevention: Postulated
mechanisms and in-vivo evidence. Int J Mol Sci 2008;9(5):854-863
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635701/.
105. Mustapha MA, Shahpudin SN, Aziz AA, et al. Risk modification of colorectal cancer
susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol
2012;18(21):2668-2673
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370004/.
CLINICAL
106. Safari A, Shariff ZM, Kandiah M, et al. Dietary patterns and risk of colorectal cancer in
Tehran Province: a case-control study. BMC Public Health 2013;13:222-2458-13-222
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605096/.
LAB STUDIES
107. Wasito I, Hashim SZ, Sukmaningrum S. Iterative local Gaussian clustering for
expressed genes identification linked to malignancy of human colorectal carcinoma.
Bioinformation 2007;2(5):175-181
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241931/.
108. Wong TW, Colombo G, Sonvico F. Pectin matrix as oral drug delivery vehicle for colon
cancer treatment. AAPS PharmSciTech 2011;12(1):201-214
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066368/.
109. Yeoh LC, Dharmaraj S, Gooi BH, et al. Chemometrics of differentially expressed
proteins from colorectal cancer patients. World J Gastroenterol 2011;17(16):2096-2103
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084394/.
110. Yeoh LC, Loh CK, Gooi BH, et al. Hydrophobic protein in colorectal cancer in relation to
tumor stages and grades. World J Gastroenterol 2010;16(22):2754-2763
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883131/.
111. Yip KT, Das PK, Suria D, et al. A case-controlled validation study of a blood-based
seven-gene biomarker panel for colorectal cancer in Malaysia. J Exp Clin Cancer Res
2010;29:128-9966-29-128
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949823/.
112. Zahary MN, Kaur G, Abu Hassan MR, et al. Germline mutation analysis of MLH1 and
MSH2 in Malaysian Lynch syndrome patients. World J Gastroenterol 2012;18(8):814-820
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286145/.
CASE REPORT:
1. Fadli A, Azmi M, David O, et al. Isolated metacarpal bone metastasis from advanced
rectosigmoid carcinoma. International Medical Journal (IIUM) 2012;11(1):52-62
http://iiumedic.net/imjm/v1/download/Volume%2011%20No%201/IMJM%20Vol11No1-2012p59-62.pdf.
HEALTH SYSTEMS:
2. Magaji BA, Moy FM, April Camilla R, et al. Health-related quality of life among colorectal
cancer patients in Malaysia: a study protocol. BMC Cancer 2012;12:384-2407-12-384
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443003/.
PUBLIC HEALTH:
3. Rajendra S, Ho JJ. Colonic diverticular disease in a multiracial Asian patient population
has an ethnic predilection. Eur J Gastroenterol Hepatol 2005;17(8):871-875.
CLINICAL:
4. Azmi MN, Zailani MA, Norashikin MN, et al. Five-year review of histopathological findings
of colorectal cancer patients operated in Hospital Tengku Ampuan Afzan, Kuantan, Pahang,
Malaysia. International Medical Journal (IIUM) 2007;6(1)
http://www.e-imj.com/Vol6-No1/Vol6-No1-B3.htm.
HEALTH MANAGEMENT:
5. Mohamed AQ. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer
in Malaysia. Malaysian Society of Gastroenterology & Hepatology, College of Surgeons of
Malaysia, Academy of Medicine of Malaysia 2001;.
6. Qureshi MA. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer
in Malaysia. 2001;.
LAB BASED STUDY – GENETIC EPIDEMIOLOGY:
7. Chew MF, Teoh KH, Cheah PL. CD133 marks for colorectal adenocarcinoma. Malays J
Pathol 2012;34(1):25-28
http://www.mjpath.org.my/2012.1/CD133.pdf.
HEALTH SYSTEMS:
8. Sharifa Ezat WP, Natrah MS, Syed Mohd A, et al. Quality of life in Malaysian colorectal
cancer patients. Asia Pac Psychiatry 2013;5 Suppl 1:110-117
http://onlinelibrary.wiley.com/doi/10.1111/appy.12055/pdf.
PUBLIC HEALTH:
9. Loh KW, Hazreen AM, Maznah D, et al. Sociodemographic predictors of recall and
recognition of colorectal cancer symptoms and anticipated delay in help- seeking in a
multiethnic asian population. Asian Pac J Cancer Prev 2013;14(6):3799-3804
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3799804%205.19%20Kwong%20Weng%20Loh.pdf.
10. Yunus AG. Surgical management of rectal cancer - no room for error. Malaysian Journal
of Medicine and Health Sciences 2008;4(1):iii-iv
http://medic.upm.edu.my/images/stories/journal/VOL4NO1_JANUARY2008.pdf;;.
HEALTH BEHAVIOUR
11. Al-Naggar RA, Bobryshev YV. Knowledge of colorectal cancer screening among young
Malaysians. Asian Pac J Cancer Prev 2013;14(3):1969-1974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/%20196974%202.21%20Redhwan%20A%20Al-Naggar.pdf.
LAB BASED – GENETIC EPID
12. Zahary MN, Ahmad Aizat AA, Gurjeet Kaur, et al. Contribution of the MLH1 -93G>a
promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer
patients. Asian Pac J Cancer Prev 2013;14(2):619-624
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/619624%208.13%20Zahary%20Mohd%20Nizam.pdf.
HEALTH BEHAVIOUR
13. Harmy MY, Norwati D, Norhayati MN, et al. Participation and barriers to colorectal
cancer screening in Malaysia. Asian Pac J Cancer Prev 2012;13(8):3983-3987
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/398387%207.24%20Harmy%20Mohamed%20Yusof.pdf.
CLINICAL
14. Ulaganathan V, Kandiah M, Zalilah MS, et al. Colorectal cancer and its association with
the metabolic syndrome: a Malaysian multi-centric case-control study. Asian Pac J Cancer
Prev 2012;13(8):3873-3877
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/387377%207.16%20Vaidehi%20Ulaganathan.pdf.
LAB BASED
15. Ashwaq Hamid Y, Narazah MY, Imran AK, et al. Pilot study of the sensitivity and
specificity of the DNA integrity assay for stool-based detection of colorectal cancer in
Malaysian patients. Asian Pac J Cancer Prev 2012;13(5):1869-1872
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/186972%204.1%20Ashwaq%20Hamid%20Yehya.pdf.
PUBLIC HEALTH:
16. Al-Jashamy K, Murad A, Zeehaida M, et al. Prevalence of colorectal cancer associated
with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract
disease patients. Asian Pac J Cancer Prev 2010;11(6):1765-1768
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20176568%2010.20%20Al-Jashamy%20Karim.pdf.
17. Kong C, April Camilla R, Law C, et al. Impact of socio-economic class on colorectal
cancer patient outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pac J Cancer Prev
2010;11(4):969-974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%2096974%20Kong.pdf.
18. Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with metabolic
diseases; experience with 138 cases from Kelantan, Malaysia. Asian Pac J Cancer Prev
2008;9(4):747-751
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c%20Othman.pdf.
19. Mohd Radzniwan AR, Aznida Firzah AA, Saharuddin A, et al. Colorectal cancer patients
in a tertiary referral centre in Malaysia: a five year follow-up review. Asian Pac J Cancer
Prev 2009;10(6):1163-1166
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1163_c_Rashid.pdf.
20. Mirnalini K, Amutha R, Zalilah MS, et al. Diet and lifestyle intervention among patients
with colorectal adenomas: rationale and design of a Malaysian study. Asian Pac J Cancer
Prev 2005;6(4):553-560
http://www.apocpcontrol.org/paper_file/issue_abs/Volume6_No4/Mirnalini%20Kandiah.pdf.
HEALTH BEHAVIOUR
21. Husna AA, Loh SY, Low WY, et al. Quality of life of multiethnic adolescents living with a
parent with cancer. Asian Pac J Cancer Prev 2012;13(12):6289-6294
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No12/628994%2011.10%20Husna%20A%20Ainuddin.pdf.
HEALTH BEHAVIOUR
22. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Perceptions of Malaysian
colorectal cancer patients regarding dietary intake: a qualitative exploration. Asian Pac J
Cancer Prev 2013;14(2):1151-1154
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/115154%201.4%20Afzaninawati%20Suria%20Yusof.pdf.
PUBLIC HEALTH
23. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Dietary patterns and risk of
colorectal cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer
Prev 2012;13(9):4713-4717
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/47137%208.16%20Afzaninawati%20Suria%20Yusof.pdf.
CLINICAL
24. Syahnaz MH, Khairani O, Tong SF, et al. Factors influencing late consultation among
patients with rectal bleeding in University Kebangsaan Malaysia Medical Centre. Asian Pac
J Cancer Prev 2010;11(5):1335-1339
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%20133539%209.27%20Ismail%20Sagap.pdf.
HEALTH BEHAVIOUR
25. Syahnaz MH, Tong SF, Khairani O, et al. Knowledge of colorectal cancer among patients
presenting with rectal bleeding and its association with delay in seeking medical advice.
Asian Pac J Cancer Prev 2011;12(8):2007-2011
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/200711%20c7.28%20Hashim.pdf.
CLINICAL
26. Ahmed SA, Rand RH, Layla KM, et al. Investigation into the controversial association of
Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009;9:4032407-9-403
http://www.biomedcentral.com.ezp.imu.edu.my/content/pdf/1471-2407-9-403.pdf.
LAB STUDIES
27. Abdul Aziz AA, Siti Nurfatimah MS, Mohd Aminudin M, et al. Association of Arg72Pro of
P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian
Pac J Cancer Prev 2011;12(11):2909-2913
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No11/290913%20c10.19%20Aizat.pdf.
CLINICAL
28. Ahmed SA, Rand RH, Fatimah AB. The association of Streptococcus bovis/gallolyticus
with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J
Exp Clin Cancer Res 2011;30:11-9966-30-11
http://www.jeccr.com/content/pdf/1756-9966-30-11.pdf.
LAB STUDIES
29. Ahmed SA, Rand RH, Fatimah AB. Molecular detection, quantification, and isolation of
Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven
potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 2010;9:249-4598-9-249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946291/pdf/1476-4598-9-249.pdf.
30. Mohamed KA, Abdalrahim FAA, Zeyad DN, et al. Cat's whiskers tea (Orthosiphon
stamineus) extract inhibits growth of colon tumor in nude mice and angiogenesis in
endothelial cells via suppressing VEGFR phosphorylation. Nutr Cancer 2012;64(1):89-99
http://ezproxy.upm.edu.my:2085/doi/pdf/10.1080/01635581.2012.630160.
31. Balraj P, Ruhana S. PTEN mutation studies in Malaysian colorectal cancer patients. Asia
Pacific Journal of Molecular Biology and Biotechnology 2007;15(1):23-25
http://www.msmbb.org.my/apjmbb/html151/151d.pdf.
32. Fatemeh A, Maznah I, Hosseinkhani H, et al. Effects of CXCR4 siRNA/dextran-spermine
nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal
cancer metastasis to the liver. Cancer Manag Res 2011;3:301-309
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173020/pdf/cmr-3-301.pdf.
33. Chandramathi S, Suresh KG, Anita ZB, et al. Attenuation of hydrogen peroxide and
ferric reducing/antioxidant power serum levels in colorectal cancer patients with intestinal
parasitic infection. Malays J Med Sci 2009;16(2):15-20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336169/pdf/mjms-16-2-015.pdf.
34. Lim SR, Gooi BH, Singh M, et al. Analysis of differentially expressed proteins in
colorectal cancer using hydroxyapatite column and SDS-PAGE. Appl Biochem Biotechnol
2011;165(5-6):1211-1224.
PUBLIC HEALTH
35. Hilmi I, Goh KL. Commentary: adherence and detection rates in colorectal cancer
screening. Aliment Pharmacol Ther 2013;37(1):156-7; discussion 157-8.
HEALTH BEHAVIOUR
36. Koo JH, Leong RW, Ching J, et al. Knowledge of, attitudes toward, and barriers to
participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter
study. Gastrointest Endosc 2012;76(1):126-135.
CLNICAL
37. Wendy L, Radzi M. New registry: National Cancer Patient Registry--Colorectal Cancer.
Med J Malaysia 2008;63 Suppl C:57-58.
LAB STUDIES
38. Mirakhorli M, Rahman SA, Abdullah S, et al. Multidrug resistance protein 2 genetic
polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4
chemotherapy. Mol Med Rep 2013;7(2):613-617.
39. Ho K, Yazan LS, Ismail N, et al. Apoptosis and cell cycle arrest of human colorectal
cancer cell line HT-29 induced by vanillin. Cancer Epidemiol 2009;33(2):155-160.
CLINICAL
40. Tan YM, Rosmawati M, Ranjeev P, et al. Predictive factors by multivariate analysis for
colorectal cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol
2002;17(3):281-284.
41. Roslani AC, Abdullah T, Arumugam K. Screening for colorectal neoplasias with fecal
occult blood tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev
2012;13(1):237-241.
42. Ghazali AK, Musa KI, Naing NN, et al. Prognostic factors in patients with colorectal
cancer at Hospital Universiti Sains Malaysia. Asian J Surg 2010;33(3):127-133.
43. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis
2007;8(4):179-185.
LAB STUDIES
44. Tan LP, Ng BK, Balraj P, et al. No difference in the occurrence of mismatch repair
defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient
cohort. Pathology 2007;39(2):228-234.
45. Yip WK, Choo CW, Leong VC, et al. Molecular alterations of Ras-Raf-mitogen-activated
protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal
cancers from a tertiary hospital at Kuala Lumpur, Malaysia. APMIS 2013;121(10):954-966.
46. Abdul Murad NA, Othman Z, Khalid M, et al. Missense mutations in MLH1, MSH2, KRAS,
and APC genes in colorectal cancer patients in Malaysia. Dig Dis Sci 2012;57(11):28632872.
47. Davoodi H, Seow HF. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and
Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy
Asthma Immunol 2011;10(2):91-99.
48. Zulhabri O, Rahman J, Ismail S, et al. Predominance of G to A codon 12 mutation K-ras
gene in Dukes' B colorectal cancer. Singapore Med J 2012;53(1):26-31
http://www.ncbi.nlm.nih.gov/pubmed/22252179.
49. Yam YY, Hoh BP, Othman NH, et al. Somatic copy-neutral loss of heterozygosity and
copy number abnormalities in Malaysian sporadic colorectal carcinoma patients. Genet Mol
Res 2013;12(1):319-327.
50. Ching-Shian Leong V, Jabal MF, Leong PP, et al. PIK3CA gene mutations in breast
carcinoma in Malaysian patients. Cancer Genet Cytogenet 2008;187(2):74-79.
HEALTH BEHAVIOUR
51. Harmy MY, Norwati D, Noor NM, et al. Knowledge and attitude of colorectal cancer
screening among moderate risk patients in West Malaysia. Asian Pac J Cancer Prev
2011;12(8):1957-1960.
52. Hilmi I, Hartono JL, Goh K. Negative perception in those at highest risk--potential
challenges in colorectal cancer screening in an urban asian population. Asian Pac J Cancer
Prev 2010;11(3):815-822.
CLINICAL
53. Gul YA. Management of colorectal cancer--can we do better? Med J Malaysia
2008;63(2):89-90
http://www.e-mjm.org/2008/v63n2/Colorectal_Cancer.pdf.
LAB STUDIES
54. Chandramathi S, Suresh K, Anita ZB, et al. Infections of Blastocystis hominis and
microsporidia in cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg
2012;106(4):267-269.
CLINICAL
55. Kamil M, Haron M, Yosuff N, et al. High frequency of hand foot syndrome with
capecitabine. J Coll Physicians Surg Pak 2010;20(6):421-422.
CASE REPORT
56. Ng CV. Hypersensitivity reactions to oxaliplatin in two asian patients. Ann
Pharmacother 2005;39(6):1114-1118.
CLINICAL
57. Dranitsaris G, Truter I, Lubbe MS. The development of a value based pricing index for
new drugs in metastatic colorectal cancer. Eur J Cancer 2011;47(9):1299-1304.
LAB STUDIES
58. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 mediate 2-(3,4dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and
colorectal cancer cells. Mol Cancer Ther 2011;10(10):1982-1992.
CLINICAL
59. Amutha R, Mirnalini K. Food intake and colorectal adenomas: a case-control study in
Malaysia. Asian Pac J Cancer Prev 2009;10(5):925-932
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/925%20Ramadas.pdf.
LAB STUDIES
60. Khor TO, Gul YA, Ithnin H, et al. Positive correlation between overexpression of
phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal
carcinoma. Cancer Lett 2004;210(2):139-150.
61. Khor TO, Gul YA, Ithnin H, et al. A comparative study of the expression of Wnt-1, WISP1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 2006;21(4):291-300.
62. Chan KH, Chandramathi S, Suresh K, et al. Effects of symptomatic and asymptomatic
isolates of Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res
2012;110(6):2475-2480.
63. Chandramathi S, Suresh K, Kuppusamy UR. Solubilized antigen of Blastocystis hominis
facilitates the growth of human colorectal cancer cells, HCT116. Parasitol Res
2010;106(4):941-945.
64. Jada SR, Lim R, Wong CI, et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A
polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci
2007;98(9):1461-1467.
65. Yaacob NS, Darus HM, Norazmi MN. Modulation of cell growth and PPARgamma
expression in human colorectal cancer cell lines by ciglitazone. Exp Toxicol Pathol
2008;60(6):505-512.
CLINICAL
66. Hilmi I, Goh KL. Chemoprevention of colorectal cancer with nonsteroidal antiinflammatory drugs. Chin J Dig Dis 2006;7(1):1-6.
LAB STUDIES
67. Hong SK, Gul YA, Ithnin H, et al. Expression of beta-catenin, COX-2 and iNOS in
colorectal cancer: relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia. Asian J
Surg 2004;27(1):10-17.
CLINICAL
68. Teoh CM, Gunasegaram T, Chan KY, et al. Review of risk factors associated with the
anastomosis leakage in anterior resection in Hospital Universiti Kebangsaan Malaysia. Med
J Malaysia 2005;60(3):275-280
http://www.e-mjm.org/2005/v60n3/Anastomosis_Leakage.pdf.
LAB STUDIES
69. Naik VR, Jaafar H, Seng CE. Lymphatic channel density in colorectal adenocarcinoma.
Indian J Pathol Microbiol 2010;53(1):12-14.
CLINICAL
70. bin Sabir Husin Athar PP, bte Ahmad Norhan N, bin Saim L, et al. Metastasis to the
sinonasal tract from sigmoid colon adenocarcinoma. Ann Acad Med Singapore
2008;37(9):788-783.
LAB STUDIES
71. Rajendra S, Ho JJ, Arokiasamy J. Risk of colorectal adenomas in a multiethnic Asian
patient population: race does not matter. J Gastroenterol Hepatol 2005;20(1):51-55.
72. Goh KS, Ong TA, Peh SC, et al. P53 expression in colorectal carcinoma: the University
of Malaya Medical Centre's experience. Med J Malaysia 2004;59(4):515-521
http://www.e-mjm.org/2004/v59n4/Colorectal_Carcinoma.pdf.
HEALTH BEHAVIOUR
73. Natrah MS, Ezat S, Syed MA, et al. Quality of life in Malaysian colorectal cancer
patients: a preliminary result. Asian Pac J Cancer Prev 2012;13(3):957-962.
CLINICAL
74. Mahadeva S, Rembacken BJ. Standard "inject and cut" endoscopic mucosal resection
technique is practical and effective in the management of superficial colorectal
neoplasms. Surg Endosc 2009;23(2):417-422.
LAB STUDIES
75. Chandramathi S, Suresh K, Anita ZB, et al. Comparative assessment of urinary
oxidative indices in breast and colorectal cancer patients. J Cancer Res Clin Oncol
2009;135(2):319-323.
CLINICAL
76. Primrose JN. Managing liver metastases: myth or reality? Med J Malaysia 2005;60 Suppl
B:67-69.
77. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping
in colorectal cancer. ANZ J Surg 2008;78(9):775-779.
LAB STUDIES
78. Chan TH, Goh KL. Appropriateness of colonoscopy using the ASGE guidelines:
experience in a large Asian hospital. Chin J Dig Dis 2006;7(1):24-32.
79. Lim MS, Melich G, Min BS. Robotic single-incision anterior resection for sigmoid colon
cancer: access port creation and operative technique. Surg Endosc 2013;27(3):1021-0122549-0. Epub 2012 Oct 10.
CLINICAL
80. Cheong KL, Roohi S, Jarmin R, et al. The yield for colorectal cancer and adenoma by
indication at colonoscopy. Med J Malaysia 2000;55(4):464-466
http://www.e-mjm.org/2000/v55n4/Colonoscopy.pdf.
LAB STUDIES
81. Lim SR, Gooi BH, Gam LH. Identification of low abundance proteins in colorectal cancer
tissues. Cancer Biomark 2012;12(4):185-198.
HEALTH BEHAVIOUR
82. Goh KL, Quek KF, Yeo GT, et al. Colorectal cancer in Asians: a demographic and
anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther
2005;22(9):859-864.
LAB STUDIES
83. Aisha AF, Abu-Salah KM, Ismail Z, et al. alpha-Mangostin enhances betulinic acid
cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells.
Molecules 2012;17(3):2939-2954.
84. Nassar ZD, Aisha AF, Idris N, et al. Koetjapic acid, a natural triterpenoid, induces
apoptosis in colon cancer cells. Oncol Rep 2012;27(3):727-733.
85. Ashok Kumar P, Norhaizan ME. Dietary non-nutritive factors in targeting of regulatory
molecules in colorectal cancer: an update. Asian Pac J Cancer Prev 2013;14(10):5543-5552
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/55435552%207.25%20Ashok%20Kumar%20Pandurangan%20%28REVIEW%29.pdf.
86. Leong BD, Ramu P, Kumar VM, et al. Synchronous adenocarcinoma of caecum,
transverse colon and jejunum. Med J Malaysia 2008;63(2):148-149
http://www.e-mjm.org/2008/v63n2/Synchronous_Adenocarcinoma.pdf.
87. Rajendra S, Kutty K, Karim N. Flat colonic adenomas in Malaysia: fact or fancy? J
Gastroenterol Hepatol 2003;18(6):701-704.
88. Tan LP, Ng BK, Balraj P, et al. Gene symbol: APC. Disease: colorectal cancer. Hum
Genet 2005;118(3-4):545.
89. Venkatesh RN, Jaafar H, Mutum SS. Heterotopic ossification in skeletal muscle
metastasis from colonic adenocarcinoma--a case report. Malays J Pathol 2005;27(2):119121
http://www.mjpath.org.my/past_issue/MJP2005.2/08Heteropic.pdf.
CLINICAL
90. Harris Ngow A, Wan Khairina W. Cardiac mass in a patient with sigmoid
adenocarcinoma: a metastasis? Cardiovasc J Afr 2012;23(7):e10-e12
http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=22915057&site=ehostlive.
CASE REPORT
91. Chan KY, Teoh CM, Sukumar N. Chylous ascites after anterior resection for rectal
carcinoma: a rare but significant incident. Asian J Surg 2006;29(1):46-48.
LAB STUDIES
92. Hisham RB, Thuaibah H, Gul YA. Mucinous adenocarcinoma of the rectum with breast
and ocular metastases. Asian J Surg 2006;29(2):95-97.
CASE REPORT
93. Jasman J, Mayuha R, Imtiaz H, et al. Subcutaneous metastases from rectal carcinoma:
A case report. Journal of Surgical Academia 2011;1(2):23
http://journalarticle.ukm.my/2960/1/23-24.pdf.
CLINICAL
94. Law CW, Roslani AC, Ng LL. Treatment delay in rectal cancer. Med J Malaysia
2009;64(2):163-165.
95. Lee WC, Mastura MY, Lau FN, et al. Preoperative long course chemoirradiation in a
developing country for rectal carcinoma: Kuala Lumpur Hospital experience. Asian Pac J
Cancer Prev 2013;14(6):3941-3944
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3941-44%205.27%20Wei
%20Ching%20Lee.pdf.
CASE REPORT
96. Ramanathan Y, Rajagopalan R, Rahman NA. Laryngeal metastasis from a rectal
carcinoma. Ear Nose Throat J 2007;86(11):685-686.
LAB STUDIES
97. Siti Aisyah AG, Maznah I, Latifah SY, et al. Cytotoxic Activity of Kenaf Seed Oils from
Supercritical Carbon Dioxide Fluid Extraction towards Human Colorectal Cancer (HT29) Cell
Lines. Evid Based Complement Alternat Med 2013;2013:549705
http://www.hindawi.com/journals/ecam/2013/549705/.
98. Al-Joudi FS. Prognostic value of an index for serum globulin compensation in colon and
breast cancers. Singapore Med J 2005;46(12):710-713
http://www.sma.org.sg/smj/4612/4612a5.pdf.
99. Nazri A, Lio P. Investigating meta-approaches for reconstructing gene networks in a
mammalian cellular context. PLoS One 2012;7(1):e28713
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253778/.
100. Ahmad Aizat AA, Siti Nurfatimah MS, Aminudin MM, et al. XPC Lys939Gln
polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians. World J
Gastroenterol 2013;19(23):3623-3628
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691041/.
CLINICAL
101. Chan KK, Dassanayake B, Deen R, et al. Young patients with colorectal cancer have
poor survival in the first twenty months after operation and predictable survival in the
medium and long-term: analysis of survival and prognostic markers. World J Surg Oncol
2010;8:82-7819-8-82
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954852/.
LAB STUDIES
102. Ho KL, Chong PP, Yazan LS, et al. Vanillin differentially affects azoxymethane-injected
rat colon carcinogenesis and gene expression. J Med Food 2012;15(12):1096-1102
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523249/.
103. Kaur G, Masoud A, Raihan N, et al. Mismatch repair genes expression defects &
association with clinicopathological characteristics in colorectal carcinoma. Indian J Med
Res 2011;134:186-192
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181019/.
104. Liong MT. Roles of probiotics and prebiotics in colon cancer prevention: Postulated
mechanisms and in-vivo evidence. Int J Mol Sci 2008;9(5):854-863
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635701/.
105. Mustapha MA, Shahpudin SN, Aziz AA, et al. Risk modification of colorectal cancer
susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol
2012;18(21):2668-2673
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370004/.
CLINICAL
106. Safari A, Shariff ZM, Kandiah M, et al. Dietary patterns and risk of colorectal cancer in
Tehran Province: a case-control study. BMC Public Health 2013;13:222-2458-13-222
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605096/.
LAB STUDIES
107. Wasito I, Hashim SZ, Sukmaningrum S. Iterative local Gaussian clustering for
expressed genes identification linked to malignancy of human colorectal carcinoma.
Bioinformation 2007;2(5):175-181
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241931/.
108. Wong TW, Colombo G, Sonvico F. Pectin matrix as oral drug delivery vehicle for colon
cancer treatment. AAPS PharmSciTech 2011;12(1):201-214
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066368/.
109. Yeoh LC, Dharmaraj S, Gooi BH, et al. Chemometrics of differentially expressed
proteins from colorectal cancer patients. World J Gastroenterol 2011;17(16):2096-2103
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084394/.
110. Yeoh LC, Loh CK, Gooi BH, et al. Hydrophobic protein in colorectal cancer in relation to
tumor stages and grades. World J Gastroenterol 2010;16(22):2754-2763
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883131/.
111. Yip KT, Das PK, Suria D, et al. A case-controlled validation study of a blood-based
seven-gene biomarker panel for colorectal cancer in Malaysia. J Exp Clin Cancer Res
2010;29:128-9966-29-128
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949823/.
112. Zahary MN, Kaur G, Abu Hassan MR, et al. Germline mutation analysis of MLH1 and
MSH2 in Malaysian Lynch syndrome patients. World J Gastroenterol 2012;18(8):814-820
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286145/.